Zobrazeno 1 - 10
of 328
pro vyhledávání: '"FIB‐4 index"'
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 11, Pp 1246-1255 (2024)
Abstract The fibrosis‐4 index (FIB‐4) is a noninvasive fibrosis test that is recommended for patients who are at risk of developing hepatic fibrosis. The aim of the study was to explore the correlation between FIB‐4 index and the decline of cog
Externí odkaz:
https://doaj.org/article/e6a53d7bcbe049b6ae2bb5167fb9759d
Autor:
Joost Boeckmans, Maurice Michel, Alexander Gieswinkel, Oliver Tüscher, Stavros V. Konstantinides, Jochem König, Thomas Münzel, Karl J. Lackner, Jasmin Ghaemi Kerahrodi, Alexander K. Schuster, Philipp S. Wild, Peter R. Galle, Jörn M. Schattenberg
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101171- (2024)
Background & Aims: Elevated liver stiffness has been associated with atrial fibrillation (AFib) in the general population. The mechanism underlying this association is unclear. Methods: Participants were recruited from the general population and pros
Externí odkaz:
https://doaj.org/article/dbb6653caaf54e8bbf49c5a6cce8895e
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 2613-2625 (2024)
Hua Liu,1,2,* Yang-Min Hao,1,2,* Sheng Jiang,1,2,* Maiheliya Baihetiyaer,1,2 Cheng Li,3 Guo-Yao Sang,4 Zhiming Li,5 Guo-Li Du1,2,6 1State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia
Externí odkaz:
https://doaj.org/article/fabcd40cf25845f8ba2f2864f96459d1
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Post-hepatectomy liver failure (PHLF) is a potentially life-threatening complication following liver resection. Hepatocellular carcinoma (HCC) often occurs in patients with chronic liver disease, which increases the risk of PHLF. This study
Externí odkaz:
https://doaj.org/article/974e8b02e49c481f87d64f6234f46396
Autor:
Kazuya Kariyama, Miwa Kawanaka, Kazuhiro Nouso, Akiko Wakuta, Shohei Shiota, Akemi Kurisu, Aya Sugiyama, Tomoyuki Akita, Takashi Kumada, Junko Tanaka, the Real‐Life Practice Experts for HCC (RELPEC) Study Group
Publikováno v:
JGH Open, Vol 8, Iss 7, Pp n/a-n/a (2024)
Abstract Background and Aim We conducted a study using the Fibrosis‐3 (FIB‐3) index, which is the established age‐independent index of fibrosis in nonviral liver disease and addresses the limitations of the FIB‐4 index in older age group, to
Externí odkaz:
https://doaj.org/article/79e9a833ed924293ae0f419843422eec
Autor:
Yoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, Atsushi Nakajima, Tomoari Kamada, Hitoshi Yoshiji, Takumi Kawaguchi, Hiroshi Sakugawa, Asahiro Morishita, Tsutomu Masaki, Takumi Ohmura, Toshio Watanabe, Yoshioki Yoda, Nobuyuki Enomoto, Masafumi Ono, Kanako Fuyama, Kazufumi Okada, Naoki Nishimoto, Yoichi M. Ito, Hirokazu Takahashi, Yoshio Sumida
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 8, Pp 1148-1156 (2024)
Background and Aims: The clinical characteristics and risk factors involved in the development of liver fibrosis in the subtypes of steatotic liver disease (SLD) remain unknown. We examined the clinical characteristics of SLD subtypes using a large J
Externí odkaz:
https://doaj.org/article/8fc46b5475d448f3bd4a95a12cbd8638
Autor:
Hiroshi Ito, Takeshi Kimura, Shimbo Takuro, Michiaki Higashitani, Kazuki Yamamoto, Daiki Kobayashi
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12173-12186 (2023)
Abstract Background Little is known about the association between liver indicators (The FIB‐4 index, nonalcoholic fatty liver disease fibrosis score (NFS), and fatty liver index (FLI)) and cancer development in patients without preexisting liver di
Externí odkaz:
https://doaj.org/article/8221decf31ba4dc2a71ca19462b7e793
Autor:
Maryam Namakchian, Soghra Rabizadeh, Sara Seifouri, Hassan Asadigandomani, Melika Arab Bafrani, Kiana Seifouri, Foroogh Alborzi Avanaki, Armin Rajab, Manouchehr Nakhjavani, Alireza Esteghamati
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-7 (2023)
Abstract Background Metabolic-associated fatty liver disease (MAFLD), one of the most common liver diseases, is detected in patients with concomitant hepatic steatosis and Type 2 Diabetes (T2D). We looked into the relationship between Fibrosis-4 (FIB
Externí odkaz:
https://doaj.org/article/3582f658c2df43efbe958c963c8cc7ce
Autor:
Hidenori Toyoda, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 8, Pp 1093-1102 (2023)
Background and Aims: Nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH) can cause hepatocellular carcinoma (HCC). We examined histological features and reported noninvasive markers/models for stratifying the risk of HCC
Externí odkaz:
https://doaj.org/article/565057de6be7408291dbc2b4ff90b031
Publikováno v:
Journal of Pediatric Research, Vol 9, Iss 4, Pp 368-375 (2022)
Aim:Overall, around 14-18% of non-acquired immunodeficiency syndrome-related deaths are due to liver disease in human immunodeficiency virus (HIV) patients. With a prevalence of 15%, cirrhosis appears to be a more serious consequence. There are many
Externí odkaz:
https://doaj.org/article/c51c16ca6571474ea90a30a60dd45a95